Gossamer Bio, Inc. (GOSS)
2.52
+0.07
(+2.86%)
USD |
NASDAQ |
Jan 16, 16:00
2.60
+0.08
(+3.17%)
After-Hours: 20:00
Gossamer Bio Shareholders Equity (Quarterly): -82.33M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| XOMA Royalty Corp. | 107.96M |
| Rezolute, Inc. | 147.17M |
| Axsome Therapeutics, Inc. | 73.73M |
| Crinetics Pharmaceuticals, Inc. | 1.072B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 208.82M |
| Total Liabilities (Quarterly) | 291.15M |
| Debt to Equity Ratio | -2.464 |
| Current Ratio | 3.284 |
| Net Debt Paydown Yield | -0.13% |